Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

New mGluR5 antagonists prepared and tested at Addex

Oct. 26, 2004

Topiramate as a novel approach to alcoholism

Oct. 19, 2004

Promising clinical results reported for NicVAX in smoking cessation

Oct. 4, 2004

Full enrollment reached in phase II trial of CYT002-NicQb

Sep. 30, 2004

BPC-157 lessens effects of alcohol intoxication and withdrawal

Sep. 29, 2004

DOR BioPharma receives grant for ricin toxin vaccine work

Sep. 16, 2004

DigiFab submitted for approval in U.K.

Sep. 8, 2004

NRP-104 given fast track status for treating cocaine dependence

Sep. 3, 2004

Campral receives FDA approval

Aug. 3, 2004

Results of first phase III multicenter study of naltrexone depot formulation

July 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...